Bone health of adult hemodialysis patients is related to vitamin K status

被引:69
作者
Kohlmeier, M
Saupe, J
Shearer, MJ
Schaefer, K
Asmus, G
机构
[1] UNIV N CAROLINA,SCH MED,CHAPEL HILL,NC 27599
[2] FREE UNIV BERLIN,INST KLIN CHEM & BIOCHEM,D-1000 BERLIN,GERMANY
[3] KRANKENHAUS MOABIT,DEPT INTERNAL MED 3,BERLIN,GERMANY
[4] ST THOMAS HOSP,HAEMOPHILIA CTR,LONDON,ENGLAND
[5] ST JOSEPHS HOSP,DEPT INTERNAL MED,BERLIN,GERMANY
关键词
D O I
10.1038/ki.1997.166
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
This investigation of 68 hemodialysis patients (ages 33 to 91) analyzed the association of biochemical indicators of vitamin K nutriture and bone metabolism, and related both to past bone fracture history and prospective bone fracture risk. Phylloquinone concentrations were significantly lower in the 23 patients with previous fractures compared to those without (0.93 vs. 1.50 nmol/liter, P < 0.003) and a smaller percentage of their serum osteocalcin was carboxylated (48.8 vs. 53.6%, P < 0.03). The 41 patients who never had fractures had nearly three times higher phylloquinone concentrations than the nine patients with fractures during a four-year follow-up period (1.59 vs. 0.55 nmol/liter, P < 0.002) and more carboxylated serum osteocalcin (55.2 vs. 42.0%, P < 0.01). None of the patients with phylloquinone concentrations over 2.2 nmol/liter had elevated intact parathyroid hormone (iPTH) concentrations, and only patients with less than 1 nmol/liter phylloquinone had severe hyperparathyroidism (iPTH > 300 ng/liter). Our data thus indicate that suboptimal vitamin K nutriture in hemodialysis patients is associated both with increased bone fracture risk and with a high prevalence of hyperparathyroidism.
引用
收藏
页码:1218 / 1221
页数:4
相关论文
共 18 条
[1]  
AKIBA T, 1991, Journal of the American Society of Nephrology, V2, P608
[2]   HYPERPARATHYROIDISM IS RESPONSIBLE FOR THE INCREASED LEVELS OF OSTEOCALCIN IN PATIENTS WITH NORMALLY FUNCTIONING KIDNEY GRAFTS [J].
AMADO, JA ;
RIANCHO, JA ;
DEFRANCISCO, ALM ;
COTORRUELO, JG ;
FEIJANES, J ;
ARIAS, M ;
NAPAL, J ;
GONZALEZMACIAS, J .
NEPHRON, 1989, 52 (03) :209-215
[3]   CIRCULATING VITAMIN-K LEVELS IN PATIENTS WITH FRACTURES [J].
BITENSKY, L ;
HART, JP ;
CATTERALL, A ;
HODGES, SJ ;
PILKINGTON, MJ ;
CHAYEN, J .
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 1988, 70 (04) :663-664
[4]  
DUQUETTE C, 1994, FASEB J, V8, pA191
[5]   ELECTROCHEMICAL DETECTION OF DEPRESSED CIRCULATING LEVELS OF VITAMIN-K1 IN OSTEOPOROSIS [J].
HART, JP ;
SHEARER, MJ ;
KLENERMAN, L ;
CATTERALL, A ;
REEVE, J ;
SAMBROOK, PN ;
DODDS, RA ;
BITENSKY, L ;
CHAYEN, J .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 60 (06) :1268-1269
[6]   DEPRESSED LEVELS OF CIRCULATING MENAQUINONES IN PATIENTS WITH OSTEOPOROTIC FRACTURES OF THE SPINE AND FEMORAL-NECK [J].
HODGES, SJ ;
PILKINGTON, MJ ;
STAMP, TCB ;
CATTERALL, A ;
SHEARER, MJ ;
BITENSKY, L ;
CHAYEN, J .
BONE, 1991, 12 (06) :387-389
[7]   THE EFFECT OF VITAMIN-K SUPPLEMENTATION ON CIRCULATING OSTEOCALCIN (BONE GLA PROTEIN) AND URINARY CALCIUM EXCRETION [J].
KNAPEN, MHJ ;
HAMULYAK, K ;
VERMEER, C .
ANNALS OF INTERNAL MEDICINE, 1989, 111 (12) :1001-1005
[8]   VITAMIN K-INDUCED CHANGES IN MARKERS FOR OSTEOBLAST ACTIVITY AND URINARY CALCIUM LOSS [J].
KNAPEN, MHJ ;
JIE, KSG ;
HAMULYAK, K ;
VERMEER, C .
CALCIFIED TISSUE INTERNATIONAL, 1993, 53 (02) :81-85
[9]  
KOHLMEIER M, 1995, THROMB HAEMOSTASIS, V74, P1252
[10]  
ORIMO H, 1992, CLIN EVAL, V20, P45